National and Kapodistrian University of Athens
Low flow low gradient aortic valve stenosis: the role of transcatheter aortic valve replacement (TAVR)
Abstract
dc:descriptionBackground: Few data exist on comparative long-term outcomes of severe aortic stenosis (AS) patients with different flow-gradient patterns undergoing transcatheter aortic valve replacement (TAVR). This study sought to evaluate the impact of pre-TAVR flow-gradient pattern on long-term clinical outcomes after TAVR and assess changes in left ventricular ejection fraction (LVEF) of different phenotypes of AS patients following TAVR. Methods: Consecutive patients with severe AS undergoing TAVR in our institution were screened and prospectively enrolled. Patients were divided in four subgroups according to pre-TAVR flow/gradient pattern: (i) low flow - low gradient (LF-LG): stroke volume indexed (SVi) ≤ 35ml/m2 and mean gradient (MG) < 40mmHg), (ii) normal flow - low gradient (NF-LG): SVi > 35ml/m2 and MG < 40mmHg, (iii) low flow - high gradient (LF-HG) : Svi 35ml/m2 and MG ≥ 40mmHg and (iv) normal flow - high gradient (NF-HG): SVi > 35 ml/m2 and MG ≥ 40mmHg. Transthoracic echocardiography was repeated at 1-year follow-up. Clinical follow-up was obtained at 12 months, and yearly thereafter until 5-year follow up was complete for all patients. Results: A total of 272 patients with complete echocardiographic and clinical follow-up were included in our analysis. Their mean age was 80±7 years and the majority of patients (N=138, 50.8%) were women. 62 patients (22.8% of the study population) were distributed in LF-LG group, 98 patients (36%) were LF-HG patients, 95 patients (34.9%) were NF-HG, while 17 patients (6.3%) were NF-LG. There was a greater prevalence of comorbidities among LF-LG AS patients. One-year all-cause mortality differed significantly between the four subgroups of AS patients (log rank p: 0.022) and was more prevalent among LF-LG patients (25.8%) compared to LF-HG (11.3%), NF-HG (6.3%) and NF-LG patients (18.8%). At 5-year follow-up, global mortality remained persistently higher among LF-LG patients (64.5%) compared to LF-HG (47.9%), NF-HG (42.9%) and NF-LG patients (58.8%) (log rank p: 0.029). At multivariable Cox hazard regression analysis, baseline SVi (HR: 0.951, 95% C.I.; 0.918 – 0.984), the presence of at least moderate tricuspid regurgitation at baseline (HR: 3.091, 95% C.I: 1.645 - 5.809) and at least moderate paravalvular leak (PVL) post-TAVR (HR: 1.456 , 95% C.I.: 1.106 - 1.792 ) were significant independent predictors of late global mortality. LF-LG patients and LF-HG patients exhibited a significant increase in LVEF at 1-year follow-up. A lower LVEF (p<0.001) and a lower Svi (p<0.001) at baseline were associated with LVEF improvement at 1 year. Conclusions: Patients with LF-LG AS have acceptable 1-year outcomes with significant improvement in LVEF at 1 year follow-up, but exhibit an exceedingly high 5-year mortality following TAVR. The presence of low transvalvular flow and at least moderate tricuspid regurgitation at baseline and significant paravalvular leak post- TAVR were associated with poorer long-term outcomes in the entire cohort of AS patients. The presence of a low LVEF or a low SVi predicts LVEF improvement at 1-year.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2026
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Oikonomou, Georgios
- Οικονόμου, Γεώργιος
Subjects
dc:subject × 20- Στένωση αορτικής βαλβίδας
- Χαμηλής ροής-χαμηλής κλίσης πίεσης
- Δείκτης όγκου παλμού
- Κλάσμα εξωθήσεως αριστεράς κοιλίας
- Διακαθετηριακή αντικατάσταση αορτικής βαλβίδας
- Ολική θνησιμότητα
- Καρδιαγγειακή θνησιμότητα
- Aortic stenosis
- Low flow- low gradient
- Stroke volume index
- Left ventricular ejection fraction
- Transcatheter aortic valve replacement
- All-cause mortality
- Cardiovascular mortality
- Κλινική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Καρδιολογία και Καρδιοαγγειακά νοσήματα
- Clinical Medicine
- Medical and Health Sciences
- Cardiology and Cardiovascular Medicine
Rights
- Language dc:language
- eng
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/61626